Trademark: NUCLEUS NETWORK 2202814
Word
NUCLEUS NETWORK
ID
2202814
Trademark Type
Word
Status
Registered: Registered/protected
Application Date
16 August 2021
Registration Date
16 August 2021
Renewal Date
16 August 2031
Owner(s)
Service
Banki Haddock Fiora
Goods and Services:
Class 42:
Conducting clinical trials, including conducting early-stage clinical trials in the field of pharmaceuticals; conducting scientific studies; conducting clinical research; scientific research services in the fields of medicine and pharmaceuticals; research and development services in the fields of medicine and pharmaceuticals; preparation of reports in the fields of medicine and pharmaceuticals; providing scientific analysis of results of clinical trials; providing of scientific information; advisory and consultancy services in relation to all of the foregoing
Conducting clinical trials, including conducting early-stage clinical trials in the field of pharmaceuticals; conducting scientific studies; conducting clinical research; scientific research services in the fields of medicine and pharmaceuticals; research and development services in the fields of medicine and pharmaceuticals; preparation of reports in the fields of medicine and pharmaceuticals; providing scientific analysis of results of clinical trials; providing of scientific information; advisory and consultancy services in relation to all of the foregoing
Class 44:
Medical services; medical diagnostic services; medical screening services; health care consultancy services; health assessment services; conducting of medical examinations; preparation of medical reports; providing information, including online, regarding medical services and pharmaceuticals; advisory and consultancy services in relation to all of the foregoing
Medical services; medical diagnostic services; medical screening services; health care consultancy services; health assessment services; conducting of medical examinations; preparation of medical reports; providing information, including online, regarding medical services and pharmaceuticals; advisory and consultancy services in relation to all of the foregoing